Oral glucose tolerance testing in an outpatient heart failure clinic reveals a high proportion of undiagnosed diabetic patients with an adverse prognosis. Eur J Heart Fail. 2011;13:319 326. doi: 10.1093/eurjhf/hfq216. 111. Aguilar D, Solomon SD, K ber L, Rouleau JL, Skali H, McMurray JJ, Francis GS, Henis M, O Connor CM, Diaz R, Belenkov YN, Varshavsky S, Leimberger JD, Velazquez EJ, Califf RM, Pfeffer MA. Newly diag- nosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation. 2004;110:1572 1578. doi: 10.1161/01.CIR.0000142047.28024.F2. 112. Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, Haffner S, Katz R, Lindenfeld J, Lowes BD, Martin W, McGrew F, Bristow MR; BEST Investigators. The effect of dia- betes on outcomes of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol. 2003;42:914 922. 113. MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB, Solomon SD, Granger CB, Swedberg K, Yusuf S, Pfeffer MA, McMurray JJ; CHARM Investigators. Impact of diabetes on out- comes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29:1377 1385. doi: 10.1093/eurheartj/ehn153. 114. Murcia AM, Hennekens CH, Lamas GA, Jim nez-Navarro M, Rouleau JL, Flaker GC, Goldman S, Skali H, Braunwald E, Pfeffer MA. Impact of diabetes on mortality in patients with myocar- dial infarction and left ventricular dysfunction. Arch Intern Med. 2004;164:2273 2279. doi: 10.1001/archinte.164.20.2273. Shah AM, Uno H, K ber L, Velazquez EJ, Maggioni AP, MacDonald MR, Petrie MC, McMurray JJ, Califf RM, Pfeffer MA, Solomon SD. The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction. Eur J Heart Fail. 